322 related articles for article (PubMed ID: 32029477)
1. Pausing sites of RNA polymerase II on actively transcribed genes are enriched in DNA double-stranded breaks.
Singh S; Szlachta K; Manukyan A; Raimer HM; Dinda M; Bekiranov S; Wang YH
J Biol Chem; 2020 Mar; 295(12):3990-4000. PubMed ID: 32029477
[TBL] [Abstract][Full Text] [Related]
2. Release of paused RNA polymerase II at specific loci favors DNA double-strand-break formation and promotes cancer translocations.
Dellino GI; Palluzzi F; Chiariello AM; Piccioni R; Bianco S; Furia L; De Conti G; Bouwman BAM; Melloni G; Guido D; Giacò L; Luzi L; Cittaro D; Faretta M; Nicodemi M; Crosetto N; Pelicci PG
Nat Genet; 2019 Jun; 51(6):1011-1023. PubMed ID: 31110352
[TBL] [Abstract][Full Text] [Related]
3. DNA topoisomerase I inhibition by camptothecin induces escape of RNA polymerase II from promoter-proximal pause site, antisense transcription and histone acetylation at the human HIF-1alpha gene locus.
Baranello L; Bertozzi D; Fogli MV; Pommier Y; Capranico G
Nucleic Acids Res; 2010 Jan; 38(1):159-71. PubMed ID: 19854946
[TBL] [Abstract][Full Text] [Related]
4. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
Wong ML; Hsu MT
J Virol; 1990 Feb; 64(2):691-9. PubMed ID: 2153235
[TBL] [Abstract][Full Text] [Related]
5. RNA Polymerase II Promoter-Proximal Pausing and Release to Elongation Are Key Steps Regulating Herpes Simplex Virus 1 Transcription.
Birkenheuer CH; Baines JD
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826988
[TBL] [Abstract][Full Text] [Related]
6. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase II contributes to DNA secondary structure-mediated double-stranded breaks.
Szlachta K; Manukyan A; Raimer HM; Singh S; Salamon A; Guo W; Lobachev KS; Wang YH
Nucleic Acids Res; 2020 Jul; 48(12):6654-6671. PubMed ID: 32501506
[TBL] [Abstract][Full Text] [Related]
8. Mapping DNA Breaks by Next-Generation Sequencing.
Baranello L; Kouzine F; Wojtowicz D; Cui K; Zhao K; Przytycka TM; Capranico G; Levens D
Methods Mol Biol; 2018; 1672():155-166. PubMed ID: 29043624
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide RNA pol II initiation and pausing in neural progenitors of the rat.
Scheidegger A; Dunn CJ; Samarakkody A; Koney NK; Perley D; Saha RN; Nechaev S
BMC Genomics; 2019 Jun; 20(1):477. PubMed ID: 31185909
[TBL] [Abstract][Full Text] [Related]
10. Alternative DNA secondary structure formation affects RNA polymerase II promoter-proximal pausing in human.
Szlachta K; Thys RG; Atkin ND; Pierce LCT; Bekiranov S; Wang YH
Genome Biol; 2018 Jul; 19(1):89. PubMed ID: 30001206
[TBL] [Abstract][Full Text] [Related]
11. Elongation by RNA polymerase II on chromatin templates requires topoisomerase activity.
Mondal N; Zhang Y; Jonsson Z; Dhar SK; Kannapiran M; Parvin JD
Nucleic Acids Res; 2003 Sep; 31(17):5016-24. PubMed ID: 12930951
[TBL] [Abstract][Full Text] [Related]
12. Topoisomerase IIα represses transcription by enforcing promoter-proximal pausing.
Herrero-Ruiz A; Martínez-García PM; Terrón-Bautista J; Millán-Zambrano G; Lieberman JA; Jimeno-González S; Cortés-Ledesma F
Cell Rep; 2021 Apr; 35(2):108977. PubMed ID: 33852840
[TBL] [Abstract][Full Text] [Related]
13. Early effects of topoisomerase I inhibition on RNA polymerase II along transcribed genes in human cells.
Khobta A; Ferri F; Lotito L; Montecucco A; Rossi R; Capranico G
J Mol Biol; 2006 Mar; 357(1):127-38. PubMed ID: 16427078
[TBL] [Abstract][Full Text] [Related]
14. CNCC: an analysis tool to determine genome-wide DNA break end structure at single-nucleotide resolution.
Szlachta K; Raimer HM; Comeau LD; Wang YH
BMC Genomics; 2020 Jan; 21(1):25. PubMed ID: 31914926
[TBL] [Abstract][Full Text] [Related]
15. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes.
Zhang H; Wang JC; Liu LF
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1060-4. PubMed ID: 2829214
[TBL] [Abstract][Full Text] [Related]
16. Conserved DNA sequence features underlie pervasive RNA polymerase pausing.
Gajos M; Jasnovidova O; van Bömmel A; Freier S; Vingron M; Mayer A
Nucleic Acids Res; 2021 May; 49(8):4402-4420. PubMed ID: 33788942
[TBL] [Abstract][Full Text] [Related]
17. DNA-PK triggers histone ubiquitination and signaling in response to DNA double-strand breaks produced during the repair of transcription-blocking topoisomerase I lesions.
Cristini A; Park JH; Capranico G; Legube G; Favre G; Sordet O
Nucleic Acids Res; 2016 Feb; 44(3):1161-78. PubMed ID: 26578593
[TBL] [Abstract][Full Text] [Related]
18. RNA polymerase II pausing can be retained or acquired during activation of genes involved in the epithelial to mesenchymal transition.
Samarakkody A; Abbas A; Scheidegger A; Warns J; Nnoli O; Jokinen B; Zarns K; Kubat B; Dhasarathy A; Nechaev S
Nucleic Acids Res; 2015 Apr; 43(8):3938-49. PubMed ID: 25820424
[TBL] [Abstract][Full Text] [Related]
19. HSV-1 Infection Induces a Downstream Shift of Promoter-Proximal Pausing for Host Genes.
Weiß E; Hennig T; Graßl P; Djakovic L; Whisnant AW; Jürges CS; Koller F; Kluge M; Erhard F; Dölken L; Friedel CC
J Virol; 2023 May; 97(5):e0038123. PubMed ID: 37093003
[TBL] [Abstract][Full Text] [Related]
20. Temporal ChIP-on-Chip of RNA-Polymerase-II to detect novel gene activation events during photoreceptor maturation.
Tummala P; Mali RS; Guzman E; Zhang X; Mitton KP
Mol Vis; 2010 Feb; 16():252-71. PubMed ID: 20161818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
